Legal & General Group’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.3K Sell
4,200
-673
-14% -$5.64K ﹤0.01% 2744
2025
Q4
$36.3K Sell
4,873
-266
-5% -$1.91K ﹤0.01% 2815
2025
Q3
$34.4K Sell
5,139
-66,270
-93% -$460K ﹤0.01% 2829
2025
Q2
$473K Buy
71,409
+35,873
+101% +$254K ﹤0.01% 2459
2025
Q1
$325K Hold
35,536
﹤0.01% 2526
2024
Q4
$373K Buy
35,536
+31,975
+898% +$378K ﹤0.01% 2561
2024
Q3
$42.6K Hold
3,561
﹤0.01% 2812
2024
Q2
$20.5K Buy
+3,561
New +$19.5K ﹤0.01% 3006
2023
Q2
Sell
-2,674
Closed -$2.88K 3428
2023
Q1
$2.88K Sell
2,674
-7,447
-74% -$14.2K ﹤0.01% 3337
2022
Q4
$26.4K Hold
10,121
﹤0.01% 3092
2022
Q3
$71K Hold
10,121
﹤0.01% 2902
2022
Q2
$69K Buy
10,121
+7,364
+267% +$75.1K ﹤0.01% 2938
2022
Q1
$39K Hold
2,757
﹤0.01% 3046
2021
Q4
$40K Buy
2,757
+1,127
+69% +$16K ﹤0.01% 3078
2021
Q3
$23K Buy
1,630
+819
+101% +$12.6K ﹤0.01% 3222
2021
Q2
$14K Buy
811
+111
+16% +$1.79K ﹤0.01% 3390
2021
Q1
$11K Buy
+700
New +$9.97K ﹤0.01% 3344

Other funds holding BVS